Mr. Ball serves as Aadi’s Chief Quality Officer and SVP Manufacturing Operations, bringing 25 years of experience leading quality, manufacturing and supply chain teams in healthcare regulated industries. Most recently, Mr. Ball served as the CQO and SVP Operations at Intercept Pharmaceuticals, where he oversaw commercial product and prepared the organization to support regulatory submission of pipeline candidates. Prior to Intercept, Mr. Ball served as CQO at Immunomedics, acquired by Gilead Sciences, where he joined after serving as SVP, Global Quality and Safety, Health, and Environmental for Mallinckrodt Pharmaceuticals. Mr. Ball holds an MBA from Westminster College, a Master of Science in Biology from the University of North Carolina and a BS in Biology from Central Michigan University.